LAM launches wound gel in Latin America:
This article was originally published in Clinica
Executive Summary
Transdermal drug delivery systems specialist LAM Pharmaceutical today announced the launch of its IPM Wound Gel. Distributors and healthcare professionals from Argentina, Brazil, Costa Rica, Ecuador, El Salvador and Panama have expressed an interest in the gel, claims the Lewiston, New York-based company. It features LAM's Ionic Polymer Matrix (IPM) technology - "a combination of electrically charged and non-charged molecules with wound-healing properties". LAM has offices in Canada (Toronto) and China (Beijing).